Yin and Yang: complement activation and regulation in Alzheimer's disease.
about
Using animal models to determine the significance of complement activation in Alzheimer's diseaseCellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's diseaseTargeting neuroinflammation in Alzheimer's diseaseOxidative stress and the regulation of complement activation in human glaucomaPlasma biomarkers of brain atrophy in Alzheimer's diseaseGain in brain immunity in the oldest-old differentiates cognitively normal from demented individualsThe complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.Functional variant in complement C3 gene promoter and genetic susceptibility to temporal lobe epilepsy and febrile seizuresEvidence for an inflammatory process in age-related macular degeneration gains new support.Genetic deletion of TNFRII gene enhances the Alzheimer-like pathology in an APP transgenic mouse model via reduction of phosphorylated IκBα.Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma.Resilient emotionality and molecular compensation in mice lacking the oligodendrocyte-specific gene Cnp1Induction of complement proteins in a mouse model for cerebral microvascular A beta depositionToll-like receptor-4 mediates neuronal apoptosis induced by amyloid beta-peptide and the membrane lipid peroxidation product 4-hydroxynonenal.The role of the innate immune system in Alzheimer's disease and frontotemporal lobar degeneration: an eye on microglia.What does complement do in Alzheimer's disease? Old molecules with new insights.Expression of complement system components during aging and amyloid deposition in APP transgenic mice.The transcriptomic response of mixed neuron-glial cell cultures to 1,25-dihydroxyvitamin d3 includes genes limiting the progression of neurodegenerative diseases.Neuroinflammatory processes in Alzheimer's disease.Fibrinogen and altered hemostasis in Alzheimer's diseaseThe senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.Inflammation in Alzheimer's Disease and Molecular Genetics: Recent Update.Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma.Microglia function in Alzheimer's disease.Complement factor C5a and C5a receptor contribute to morphine tolerance and withdrawal-induced hyperalgesia in ratsA review: inflammatory process in Alzheimer's disease, role of cytokines."Immune Gate" of Psychopathology-The Role of Gut Derived Immune Activation in Major Psychiatric Disorders.
P2860
Q24796236-80D00D8E-E55E-4EED-B8FF-58B22A3D7F1AQ26849232-06AD7B93-46DB-428E-942A-40914C9D07C0Q28078474-FE1AB26C-FEE2-495B-9095-579AAAAA0463Q28577665-2D6DC52C-A4E3-4791-B944-A61A7B548E06Q28741028-88EE7F8C-8950-4453-BD0F-B624DE1F68A0Q33513475-BAA97F8D-5F6C-4CD3-8CD3-9BC54F555F33Q33685823-BCD8DCD6-5000-4F24-9CAD-58412660672AQ33700488-7E737AF7-3A83-443F-90CD-3AC864A99A7DQ33821745-E783843D-F7E9-47FE-AF9D-73B1FA6DF775Q34106250-560BD614-3877-480F-AFB8-16808F1BFD9CQ35191570-0C7FBB0F-F3BB-4C66-AF81-02F02F710D44Q35844108-2F38191F-3A50-4E14-AD84-1A4280C235EBQ36177112-8BC11AFE-B698-478A-AE4D-A70B6F46A0BCQ37003216-E7D1DE03-DA0A-4E4A-B4CF-753FC8ED9FE7Q37067641-C0E0699E-FF90-4344-BAFB-9F8663559DEFQ37368120-35059E5C-6D72-4415-B7B4-27524BB1A481Q37443394-DF5386AD-3F8E-4B9D-8EBE-EB964AF1F55AQ37656221-AA8BC398-A306-4C00-A1AD-6968118682FAQ37772809-51F9E73F-C943-454F-9666-F266C5117DDAQ38032520-F00FF39D-578E-4E4C-8C94-F5F4D7E6A503Q38094984-27AA7C1C-B8AD-48B4-85A2-11799ED89EA0Q38558744-2A0052F9-F1C5-4198-B86D-EB4FC687DDB2Q38910480-3A99F038-BF24-47D6-BC35-E5E4AE1BC1F8Q39904367-BA4B60C9-3AF5-47D3-8CEA-AF262698762CQ41014561-C4456C39-6DB3-4815-9027-14C6747046E8Q41496441-827D9BCC-9534-4262-A5C7-E22BC9D6BD55Q53328528-807048BD-C340-4475-8784-2409781E4163Q55110638-62D9CD30-C260-4868-A662-AD901D0EB5F0
P2860
Yin and Yang: complement activation and regulation in Alzheimer's disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Yin and Yang: complement activation and regulation in Alzheimer's disease.
@ast
Yin and Yang: complement activation and regulation in Alzheimer's disease.
@en
type
label
Yin and Yang: complement activation and regulation in Alzheimer's disease.
@ast
Yin and Yang: complement activation and regulation in Alzheimer's disease.
@en
prefLabel
Yin and Yang: complement activation and regulation in Alzheimer's disease.
@ast
Yin and Yang: complement activation and regulation in Alzheimer's disease.
@en
P1476
Yin and Yang: complement activation and regulation in Alzheimer's disease.
@en
P2093
P304
P356
10.1016/J.PNEUROBIO.2003.08.001
P577
2003-08-01T00:00:00Z